Principia Biopharma Inc. (PRNB) Mutually Ends Development Collaboration With AbbVie (ABBV), Reacquires Rights to Oral Immunoproteasome Program
Tweet Send to a Friend
Principia Biopharma Inc. (NASDAQ: PRNB) announced a mutual agreement with AbbVie Biotechnology Limited (NYSE: ABBV) to end their collaboration aimed ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
